UNSPSC 85813517: Introduction of other antineoplastic into subcutaneous tissue, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of other antineoplastic into subcutaneous tissue, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E01305

UNSPSC 85813517 Introduction of other antineoplastic into subcutaneous tissue, percutaneous approach, is a Commodity code that nominally describes a medical procedure for drug administration; however, the recent state and local opportunities tagged under this code show little relevance to the code's clinical scope. The most recent activity reflects requests for telehealth urgent care services, general medical services, program operations for elderly care, occupational health screening, cancer registry support, and medical director oversight—none of which align with the specific antineoplastic injection procedure the code names. The mismatch between the code's stated definition and the actual work being solicited suggests either systematic misclassification of opportunities in state and local procurement systems or that this code sees minimal appropriate activity in the public sector. State and local bodies issuing solicitations with this code tag include California health plans (Inland Empire Health Plan), Georgia counties (DeKalb County), Nevada state authorities (Nevada Health Authority), California counties (San Mateo County), Colorado counties and cities (Boulder County Sheriff's Office, City of Ocala), and Texas state agencies (Texas Health and Human Services Commission). The geographic spread spans California, Nevada, Colorado, Florida, Georgia, Texas, and other states, but opportunities cluster around broader healthcare service procurement rather than the antineoplastic procedure itself.

Representative recent opportunities illustrate the disconnect: Inland Empire Health Plan's October 31, 2026 RFI for 24/7/365 virtual urgent care services with California board-certified physicians; DeKalb County, Georgia's November 12, 2026 RFP for unspecified medical services under annual contract with renewal options; and the Nevada Health Authority's December 10, 2026 RFP for Program of All Inclusive Care for the Elderly (PACE) operations serving seniors 55 and older across multiple Nevada counties. These solicitations and others reflect occupational health, primary care, emergency medicine, and integrated health program management—service categories that fall well outside the oncology drug-administration scope UNSPSC 85813517 describes. Vendors pursuing activity tagged under this code should verify procurement intent directly with issuing bodies, as the code's use appears unreliable as a predictor of actual work scope in state and local procurement.